Tibet Weixinkang Medicine Co., Ltd. (603676.SS)

CNY 11.3

(2.26%)

Net Debt Summary of Tibet Weixinkang Medicine Co., Ltd.

  • Tibet Weixinkang Medicine Co., Ltd.'s latest annual net debt in 2023 was -261.74 Million CNY , up 49.03% from previous year.
  • Tibet Weixinkang Medicine Co., Ltd.'s latest quarterly net debt in 2024 Q3 was -240.81 Million CNY , up 31.96% from previous quarter.
  • Tibet Weixinkang Medicine Co., Ltd. reported annual net debt of -513.52 Million CNY in 2022, down -114.9% from previous year.
  • Tibet Weixinkang Medicine Co., Ltd. reported annual net debt of -238.95 Million CNY in 2021, down -12.1% from previous year.
  • Tibet Weixinkang Medicine Co., Ltd. reported quarterly net debt of -346.84 Million CNY for 2024 Q1, down -32.51% from previous quarter.
  • Tibet Weixinkang Medicine Co., Ltd. reported quarterly net debt of -240.81 Million CNY for 2024 Q3, up 31.96% from previous quarter.

Annual Net Debt Chart of Tibet Weixinkang Medicine Co., Ltd. (2023 - 2013)

Created with Highcharts 11.1.0YearsNet Debt20132014201520162017201820192020202120222023-600000000 CNY-500000000 CNY-400000000 CNY-300000000 CNY-200000000 CNY-100000000 CNY0 CNY

Historical Annual Net Debt of Tibet Weixinkang Medicine Co., Ltd. (2023 - 2013)

Year Net Debt Net Debt Growth
2023 -261.74 Million CNY 49.03%
2022 -513.52 Million CNY -114.9%
2021 -238.95 Million CNY -12.1%
2020 -213.16 Million CNY -33.5%
2019 -159.68 Million CNY -25.07%
2018 -127.67 Million CNY -69.39%
2017 -75.36 Million CNY 15.58%
2016 -89.27 Million CNY 34.51%
2015 -136.31 Million CNY -75.75%
2014 -77.55 Million CNY 22.28%
2013 -99.79 Million CNY 0.0%

Peer Net Debt Comparison of Tibet Weixinkang Medicine Co., Ltd.

Name Net Debt Net Debt Difference
Guangxi Wuzhou Zhongheng Group Co.,Ltd -1.17 Billion CNY 77.794%
Yabao Pharmaceutical Group Co., Ltd -408.64 Million CNY 35.948%
ZhuZhou QianJin Pharmaceutical Co.,Ltd -1.88 Billion CNY 86.086%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 276.38 Million CNY 194.702%
Hubei Jumpcan Pharmaceutical Co., Ltd. -6.15 Billion CNY 95.747%
North China Pharmaceutical Company Ltd. 10.74 Billion CNY 102.437%
Zhejiang Shengda Bio-Pharm Co., Ltd. -85.28 Million CNY -206.919%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.62 Billion CNY 109.966%
Shandong Buchang Pharmaceuticals Co., Ltd. 2.71 Billion CNY 109.641%
Dali Pharmaceuticalco.,Ltd 9.46 Million CNY 2864.351%
Guobang Pharma Ltd. -1.13 Billion CNY 76.855%
ChengDu ShengNuo Biotec Co.,Ltd. 48.09 Million CNY 644.246%
Changchun BCHT Biotechnology Co. -421.7 Million CNY 37.932%
Tasly Pharmaceutical Group Co., Ltd -1.49 Billion CNY 82.448%
Jiangsu Kanion Pharmaceutical Co.,Ltd. -1.92 Billion CNY 86.376%
Kangmei Pharmaceutical Co., Ltd. -801.59 Million CNY 67.347%
China Animal Husbandry Industry Co., Ltd. -36.84 Million CNY -610.396%
Shandong Lukang Pharmaceutical Co.,Ltd. 2.63 Billion CNY 109.927%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 1.69 Billion CNY 115.426%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. -244.27 Million CNY -7.15%
Shanghai Haoyuan Chemexpress Co., Ltd. 598.96 Million CNY 143.699%
Zhejiang Huahai Pharmaceutical Co., Ltd. 6.1 Billion CNY 104.284%
Harbin Pharmaceutical Group Co., Ltd. 498.52 Million CNY 152.504%
Zhejiang Medicine Co., Ltd. -658.58 Million CNY 60.257%
HPGC Renmintongtai Pharmaceutical Corporation 1.01 Billion CNY 125.692%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited -1.28 Billion CNY 79.636%
Lionco Pharmaceutical Group Co.,Ltd. 222.19 Million CNY 217.8%
Humanwell Healthcare (Group) Co.,Ltd. 5.84 Billion CNY 104.48%
Ginwa Enterprise (Group) Inc. -609.67 Million CNY 57.068%
KPC Pharmaceuticals, Inc. -321.76 Million CNY 18.653%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. -179.97 Million CNY -45.43%
Jiangsu Jibeier Pharmaceutical Co., Ltd. -684.96 Million CNY 61.787%
Ningbo Menovo Pharmaceutical Co., Ltd. 846.41 Million CNY 130.924%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd -2.47 Billion CNY 89.44%
Nanjing Well Pharmaceutical Group Co.,Ltd. 329.41 Million CNY 179.458%
Henan Lingrui Pharmaceutical Co., Ltd. -1.34 Billion CNY 80.606%
Joincare Pharmaceutical Group Industry Co.,Ltd. -8.29 Billion CNY 96.843%
China Resources Double-Crane Pharmaceutical Co.,Ltd. -2.75 Billion CNY 90.494%
Chongqing Taiji Industry(Group) Co.,Ltd 2.92 Billion CNY 108.945%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited -5.48 Billion CNY 95.224%
China National Medicines Corporation Ltd. -7.76 Billion CNY 96.63%
Shenzhen Chipscreen Biosciences Co., Ltd. 828.33 Million CNY 131.599%
Guizhou Yibai Pharmaceutical Co., Ltd. 379.62 Million CNY 168.948%
Zhongzhu Healthcare Holding Co.,Ltd -330.03 Million CNY 20.692%
Beijing Tongrentang Co., Ltd -8.7 Billion CNY 96.993%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. -1.17 Billion CNY 77.792%
Jianmin Pharmaceutical Group Co.,Ltd. 196.05 Million CNY 233.506%
CanSino Biologics Inc. 656.66 Million CNY 139.86%
Zhejiang Hisun Pharmaceutical Co., Ltd. 4.1 Billion CNY 106.376%
Shanghai Jiaoda Onlly Co.,Ltd 44.83 Million CNY 683.837%
Jiang Zhong Pharmaceutical Co.,Ltd -1.27 Billion CNY 79.492%
Mayinglong Pharmaceutical Group Co., LTD. -2.6 Billion CNY 89.963%
Cisen Pharmaceutical Co., Ltd. -812.71 Million CNY 67.794%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 149.69 Million CNY 274.847%
Hunan Warrant Pharmaceutical Co.,Ltd -355.46 Million CNY 26.365%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 25.97 Billion CNY 101.008%
Hunan Fangsheng Pharmaceutical Co., Ltd. 470.72 Million CNY 155.605%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 495.29 Million CNY 152.846%
Henan Taloph Pharmaceutical Stock Co.,Ltd 622.63 Million CNY 142.038%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 1.41 Billion CNY 118.486%
Shanghai Shyndec Pharmaceutical Co., Ltd. -3.47 Billion CNY 92.468%
Shanghai Yizhong Pharmaceutical Co., Ltd. -870.73 Million CNY 69.94%
Tibet Rhodiola Pharmaceutical Holding Co. -184.66 Million CNY -41.74%
Sichuan Huiyu Pharmaceutical Co., Ltd. -1.34 Billion CNY 80.568%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 424.4 Million CNY 161.674%